Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
02.06. | Kametstal starts production of a new steel product | - | SteelRadar | ||
02.06. | Domestic product from boron mine that revolutionises the steel industry! | - | SteelRadar | ||
02.06. | The downward trend continues in the Asian scrap market | - | SteelRadar | ||
02.06. | Hoa Phat's sales increased in April | - | SteelRadar | ||
02.06. | Indonesia's steel industry aims to produce green steel | - | SteelRadar | ||
02.06. | Amendments to some laws by the Ministry of Trade | - | SteelRadar | ||
02.06. | Gerdau increases investment in digital and innovative technologies | 3 | SteelRadar | ||
02.06. | Mubadala becomes a partner in Tubacex's UAE unit with a $150 million investment | 2 | SteelRadar | ||
02.06. | Kyrgyz-Uzbek joint auto assembly plant launches trial operation | - | SteelRadar | ||
02.06. | SYNLAIT MILK LIMITED: Change in director appointed by Bright Dairy | - | ASX | ||
02.06. | AFT PHARMACEUTICALS LIMITED: AFT to launch Maxigesic Rapid in the United States | - | ASX | ||
02.06. | ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer | 150 | GlobeNewswire (Europe) | Evorpacept in combination with PADCEV®, an approved antibody-drug conjugate ("ADC"), demonstrated promising activity and was generally well toleratedCompany to host conference call and webcast with... ► Artikel lesen | |
02.06. | Nanobiotix S.A.: Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy | 222 | GlobeNewswire (Europe) | Data show favorable safety and feasibility in 68 heavily pre-treated patients with R/M-HNSCC (Intention-to-Treat population; "ITT") who received RT-activated NBTXR3 followed by anti-PD-1 as a second-or-later... ► Artikel lesen | |
02.06. | Celldex Therapeutics, Inc.: Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2024 | 118 | GlobeNewswire (Europe) | - Clinically meaningful and statistically significant improvements across multiple angioedema measurements and barzolvolimab dose groups -- Sustained activity with rapid onset within 2 weeks -- Data... ► Artikel lesen | |
02.06. | NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Enterprise Software Support for NVIDIA IGX With Holoscan | 624 | GlobeNewswire (Europe) | TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- To address the increasing need for real-time AI computing at the industrial edge, NVIDIA today announced the general software availability... ► Artikel lesen | |
02.06. | NVIDIA Brings AI Assistants to Life With GeForce RTX AI PCs | 117 | GlobeNewswire (Europe) | TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced new NVIDIA RTX technology to power AI assistants and digital humans running on new GeForce RTX AI laptops. NVIDIA... ► Artikel lesen | |
02.06. | NVIDIA Supercharges Ethernet Networking for Generative AI | 263 | GlobeNewswire (Europe) | TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced widespread adoption of the NVIDIA Spectrum-X Ethernet networking platform as well as an accelerated product release... ► Artikel lesen | |
02.06. | NVIDIA NIM Revolutionizes Model Deployment, Now Available to Transform World's Millions of Developers Into Generative AI Developers | 160 | GlobeNewswire (Europe) | 150+ Partners Across Every Layer of AI Ecosystem Embedding NIM Inference Microservices to Speed Enterprise AI Application Deployments From Weeks to MinutesNVIDIA Developer Program Members Gain Free... ► Artikel lesen | |
02.06. | NVIDIA Releases Digital Human Microservices, Paving Way for Future of Generative AI Avatars | 159 | GlobeNewswire (Europe) | TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced the general availability of NVIDIA ACE generative AI microservices to accelerate the next wave of digital humans... ► Artikel lesen | |
02.06. | Intellia Therapeutics, Inc.: Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE) | 281 | GlobeNewswire (Europe) | Extended follow-up data reaching over two years in the earliest patients dosed reinforce the potential of NTLA-2002 to be a functional cure for people living with hereditary angioedema (HAE)Eight... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 9.811 |
EVOTEC | 4.948 |
SUPER MICRO COMPUTER | 4.014 |
BAYER | 3.894 |
NEL | 3.513 |
MICROSTRATEGY | 2.221 |
RHEINMETALL | 1.982 |
TUI | 1.656 |
TESLA | 1.620 |
THYSSENKRUPP | 1.356 |
PALANTIR TECHNOLOGIES | 1.339 |
PORSCHE AG | 1.338 |
VOLKSWAGEN | 1.171 |
RENK GROUP | 1.127 |
BIONTECH | 1.114 |
COINBASE GLOBAL | 1.047 |
GAMESTOP | 941 |
AIXTRON SE | 915 |
AMAZON | 884 |
COMMERZBANK | 858 |
SNOWFLAKE | 850 |
DEUTSCHE BANK | 847 |
MERCEDES-BENZ | 834 |
BYD | 817 |
BASF | 799 |